Service & Software
Global Cell therapy platform Market Research Report 2026
- Feb 24, 26
- ID: 717615
- Pages: 106
- Figures: 102
- Views: 4
This report delivers a comprehensive overview of the global Cell therapy platform market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Cell therapy platform. The Cell therapy platform market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Cell therapy platform market comprehensively. Regional market sizes by Type, by Application, by Treatment Cell Type, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Cell therapy platform manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Novartis
Gilead Sciences
Regeneron Pharmaceuticals
Takeda Pharmaceuticals
Roche
Bluebird Bio
Cellectis
Sangamo Therapeutics
Fate Therapeutics
Segment by Type
Autologous Cell Therapy Platform
Allogeneic Cell Therapy Platform
Others
Segment by Treatment Cell Type
Immunotherapy Platform
Stem Cell Therapy Platform
Genetically Modified Cell Therapy Platform
Segment by Technical System
Manually Operated Platform
Semi-Automated Cell Therapy Platform
Fully Automated Closed-Loop Cell Therapy Platform
Segment by Application
General Hospital
Specialized Hospital
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Treatment Cell Type, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Cell therapy platform companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
The report segments the global Cell therapy platform market comprehensively. Regional market sizes by Type, by Application, by Treatment Cell Type, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Cell therapy platform manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Novartis
Gilead Sciences
Regeneron Pharmaceuticals
Takeda Pharmaceuticals
Roche
Bluebird Bio
Cellectis
Sangamo Therapeutics
Fate Therapeutics
Segment by Type
Autologous Cell Therapy Platform
Allogeneic Cell Therapy Platform
Others
Segment by Treatment Cell Type
Immunotherapy Platform
Stem Cell Therapy Platform
Genetically Modified Cell Therapy Platform
Segment by Technical System
Manually Operated Platform
Semi-Automated Cell Therapy Platform
Fully Automated Closed-Loop Cell Therapy Platform
Segment by Application
General Hospital
Specialized Hospital
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Treatment Cell Type, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Cell therapy platform companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell therapy platform Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Autologous Cell Therapy Platform
1.2.3 Allogeneic Cell Therapy Platform
1.2.4 Others
1.3 Market by Treatment Cell Type
1.3.1 Global Cell therapy platform Market Size Growth Rate by Treatment Cell Type: 2021 vs 2025 vs 2032
1.3.2 Immunotherapy Platform
1.3.3 Stem Cell Therapy Platform
1.3.4 Genetically Modified Cell Therapy Platform
1.4 Market by Technical System
1.4.1 Global Cell therapy platform Market Size Growth Rate by Technical System: 2021 vs 2025 vs 2032
1.4.2 Manually Operated Platform
1.4.3 Semi-Automated Cell Therapy Platform
1.4.4 Fully Automated Closed-Loop Cell Therapy Platform
1.5 Market by Application
1.5.1 Global Cell therapy platform Market Growth by Application: 2021 vs 2025 vs 2032
1.5.2 General Hospital
1.5.3 Specialized Hospital
1.5.4 Others
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global Cell therapy platform Market Perspective (2021–2032)
2.2 Global Cell therapy platform Growth Trends by Region
2.2.1 Global Cell therapy platform Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Cell therapy platform Historic Market Size by Region (2021–2026)
2.2.3 Cell therapy platform Forecasted Market Size by Region (2027–2032)
2.3 Cell therapy platform Market Dynamics
2.3.1 Cell therapy platform Industry Trends
2.3.2 Cell therapy platform Market Drivers
2.3.3 Cell therapy platform Market Challenges
2.3.4 Cell therapy platform Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell therapy platform Players by Revenue
3.1.1 Global Top Cell therapy platform Players by Revenue (2021–2026)
3.1.2 Global Cell therapy platform Revenue Market Share by Players (2021–2026)
3.2 Global Top Cell therapy platform Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Cell therapy platform Revenue
3.4 Global Cell therapy platform Market Concentration Ratio
3.4.1 Global Cell therapy platform Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell therapy platform Revenue in 2025
3.5 Global Key Players of Cell therapy platform Head Offices and Areas Served
3.6 Global Key Players of Cell therapy platform, Products and Applications
3.7 Global Key Players of Cell therapy platform, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Cell therapy platform Breakdown Data by Type
4.1 Global Cell therapy platform Historic Market Size by Type (2021–2026)
4.2 Global Cell therapy platform Forecasted Market Size by Type (2027–2032)
5 Cell therapy platform Breakdown Data by Application
5.1 Global Cell therapy platform Historic Market Size by Application (2021–2026)
5.2 Global Cell therapy platform Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Cell therapy platform Market Size (2021–2032)
6.2 North America Cell therapy platform Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Cell therapy platform Market Size by Country (2021–2026)
6.4 North America Cell therapy platform Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell therapy platform Market Size (2021–2032)
7.2 Europe Cell therapy platform Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Cell therapy platform Market Size by Country (2021–2026)
7.4 Europe Cell therapy platform Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Cell therapy platform Market Size (2021–2032)
8.2 Asia-Pacific Cell therapy platform Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Cell therapy platform Market Size by Region (2021–2026)
8.4 Asia-Pacific Cell therapy platform Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Cell therapy platform Market Size (2021–2032)
9.2 Latin America Cell therapy platform Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Cell therapy platform Market Size by Country (2021–2026)
9.4 Latin America Cell therapy platform Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell therapy platform Market Size (2021–2032)
10.2 Middle East & Africa Cell therapy platform Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Cell therapy platform Market Size by Country (2021–2026)
10.4 Middle East & Africa Cell therapy platform Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Cell therapy platform Introduction
11.1.4 Novartis Revenue in Cell therapy platform Business (2021–2026)
11.1.5 Novartis Recent Development
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Details
11.2.2 Gilead Sciences Business Overview
11.2.3 Gilead Sciences Cell therapy platform Introduction
11.2.4 Gilead Sciences Revenue in Cell therapy platform Business (2021–2026)
11.2.5 Gilead Sciences Recent Development
11.3 Regeneron Pharmaceuticals
11.3.1 Regeneron Pharmaceuticals Company Details
11.3.2 Regeneron Pharmaceuticals Business Overview
11.3.3 Regeneron Pharmaceuticals Cell therapy platform Introduction
11.3.4 Regeneron Pharmaceuticals Revenue in Cell therapy platform Business (2021–2026)
11.3.5 Regeneron Pharmaceuticals Recent Development
11.4 Takeda Pharmaceuticals
11.4.1 Takeda Pharmaceuticals Company Details
11.4.2 Takeda Pharmaceuticals Business Overview
11.4.3 Takeda Pharmaceuticals Cell therapy platform Introduction
11.4.4 Takeda Pharmaceuticals Revenue in Cell therapy platform Business (2021–2026)
11.4.5 Takeda Pharmaceuticals Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Cell therapy platform Introduction
11.5.4 Roche Revenue in Cell therapy platform Business (2021–2026)
11.5.5 Roche Recent Development
11.6 Bluebird Bio
11.6.1 Bluebird Bio Company Details
11.6.2 Bluebird Bio Business Overview
11.6.3 Bluebird Bio Cell therapy platform Introduction
11.6.4 Bluebird Bio Revenue in Cell therapy platform Business (2021–2026)
11.6.5 Bluebird Bio Recent Development
11.7 Cellectis
11.7.1 Cellectis Company Details
11.7.2 Cellectis Business Overview
11.7.3 Cellectis Cell therapy platform Introduction
11.7.4 Cellectis Revenue in Cell therapy platform Business (2021–2026)
11.7.5 Cellectis Recent Development
11.8 Sangamo Therapeutics
11.8.1 Sangamo Therapeutics Company Details
11.8.2 Sangamo Therapeutics Business Overview
11.8.3 Sangamo Therapeutics Cell therapy platform Introduction
11.8.4 Sangamo Therapeutics Revenue in Cell therapy platform Business (2021–2026)
11.8.5 Sangamo Therapeutics Recent Development
11.9 Fate Therapeutics
11.9.1 Fate Therapeutics Company Details
11.9.2 Fate Therapeutics Business Overview
11.9.3 Fate Therapeutics Cell therapy platform Introduction
11.9.4 Fate Therapeutics Revenue in Cell therapy platform Business (2021–2026)
11.9.5 Fate Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell therapy platform Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Autologous Cell Therapy Platform
1.2.3 Allogeneic Cell Therapy Platform
1.2.4 Others
1.3 Market by Treatment Cell Type
1.3.1 Global Cell therapy platform Market Size Growth Rate by Treatment Cell Type: 2021 vs 2025 vs 2032
1.3.2 Immunotherapy Platform
1.3.3 Stem Cell Therapy Platform
1.3.4 Genetically Modified Cell Therapy Platform
1.4 Market by Technical System
1.4.1 Global Cell therapy platform Market Size Growth Rate by Technical System: 2021 vs 2025 vs 2032
1.4.2 Manually Operated Platform
1.4.3 Semi-Automated Cell Therapy Platform
1.4.4 Fully Automated Closed-Loop Cell Therapy Platform
1.5 Market by Application
1.5.1 Global Cell therapy platform Market Growth by Application: 2021 vs 2025 vs 2032
1.5.2 General Hospital
1.5.3 Specialized Hospital
1.5.4 Others
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global Cell therapy platform Market Perspective (2021–2032)
2.2 Global Cell therapy platform Growth Trends by Region
2.2.1 Global Cell therapy platform Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Cell therapy platform Historic Market Size by Region (2021–2026)
2.2.3 Cell therapy platform Forecasted Market Size by Region (2027–2032)
2.3 Cell therapy platform Market Dynamics
2.3.1 Cell therapy platform Industry Trends
2.3.2 Cell therapy platform Market Drivers
2.3.3 Cell therapy platform Market Challenges
2.3.4 Cell therapy platform Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell therapy platform Players by Revenue
3.1.1 Global Top Cell therapy platform Players by Revenue (2021–2026)
3.1.2 Global Cell therapy platform Revenue Market Share by Players (2021–2026)
3.2 Global Top Cell therapy platform Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Cell therapy platform Revenue
3.4 Global Cell therapy platform Market Concentration Ratio
3.4.1 Global Cell therapy platform Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell therapy platform Revenue in 2025
3.5 Global Key Players of Cell therapy platform Head Offices and Areas Served
3.6 Global Key Players of Cell therapy platform, Products and Applications
3.7 Global Key Players of Cell therapy platform, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Cell therapy platform Breakdown Data by Type
4.1 Global Cell therapy platform Historic Market Size by Type (2021–2026)
4.2 Global Cell therapy platform Forecasted Market Size by Type (2027–2032)
5 Cell therapy platform Breakdown Data by Application
5.1 Global Cell therapy platform Historic Market Size by Application (2021–2026)
5.2 Global Cell therapy platform Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Cell therapy platform Market Size (2021–2032)
6.2 North America Cell therapy platform Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Cell therapy platform Market Size by Country (2021–2026)
6.4 North America Cell therapy platform Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell therapy platform Market Size (2021–2032)
7.2 Europe Cell therapy platform Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Cell therapy platform Market Size by Country (2021–2026)
7.4 Europe Cell therapy platform Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Cell therapy platform Market Size (2021–2032)
8.2 Asia-Pacific Cell therapy platform Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Cell therapy platform Market Size by Region (2021–2026)
8.4 Asia-Pacific Cell therapy platform Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Cell therapy platform Market Size (2021–2032)
9.2 Latin America Cell therapy platform Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Cell therapy platform Market Size by Country (2021–2026)
9.4 Latin America Cell therapy platform Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell therapy platform Market Size (2021–2032)
10.2 Middle East & Africa Cell therapy platform Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Cell therapy platform Market Size by Country (2021–2026)
10.4 Middle East & Africa Cell therapy platform Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Cell therapy platform Introduction
11.1.4 Novartis Revenue in Cell therapy platform Business (2021–2026)
11.1.5 Novartis Recent Development
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Details
11.2.2 Gilead Sciences Business Overview
11.2.3 Gilead Sciences Cell therapy platform Introduction
11.2.4 Gilead Sciences Revenue in Cell therapy platform Business (2021–2026)
11.2.5 Gilead Sciences Recent Development
11.3 Regeneron Pharmaceuticals
11.3.1 Regeneron Pharmaceuticals Company Details
11.3.2 Regeneron Pharmaceuticals Business Overview
11.3.3 Regeneron Pharmaceuticals Cell therapy platform Introduction
11.3.4 Regeneron Pharmaceuticals Revenue in Cell therapy platform Business (2021–2026)
11.3.5 Regeneron Pharmaceuticals Recent Development
11.4 Takeda Pharmaceuticals
11.4.1 Takeda Pharmaceuticals Company Details
11.4.2 Takeda Pharmaceuticals Business Overview
11.4.3 Takeda Pharmaceuticals Cell therapy platform Introduction
11.4.4 Takeda Pharmaceuticals Revenue in Cell therapy platform Business (2021–2026)
11.4.5 Takeda Pharmaceuticals Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Cell therapy platform Introduction
11.5.4 Roche Revenue in Cell therapy platform Business (2021–2026)
11.5.5 Roche Recent Development
11.6 Bluebird Bio
11.6.1 Bluebird Bio Company Details
11.6.2 Bluebird Bio Business Overview
11.6.3 Bluebird Bio Cell therapy platform Introduction
11.6.4 Bluebird Bio Revenue in Cell therapy platform Business (2021–2026)
11.6.5 Bluebird Bio Recent Development
11.7 Cellectis
11.7.1 Cellectis Company Details
11.7.2 Cellectis Business Overview
11.7.3 Cellectis Cell therapy platform Introduction
11.7.4 Cellectis Revenue in Cell therapy platform Business (2021–2026)
11.7.5 Cellectis Recent Development
11.8 Sangamo Therapeutics
11.8.1 Sangamo Therapeutics Company Details
11.8.2 Sangamo Therapeutics Business Overview
11.8.3 Sangamo Therapeutics Cell therapy platform Introduction
11.8.4 Sangamo Therapeutics Revenue in Cell therapy platform Business (2021–2026)
11.8.5 Sangamo Therapeutics Recent Development
11.9 Fate Therapeutics
11.9.1 Fate Therapeutics Company Details
11.9.2 Fate Therapeutics Business Overview
11.9.3 Fate Therapeutics Cell therapy platform Introduction
11.9.4 Fate Therapeutics Revenue in Cell therapy platform Business (2021–2026)
11.9.5 Fate Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Cell therapy platform Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Autologous Cell Therapy Platform
Table 3. Key Players of Allogeneic Cell Therapy Platform
Table 4. Key Players of Others
Table 5. Global Cell therapy platform Market Size Growth Rate by Treatment Cell Type (US$ Million): 2021 vs 2025 vs 2032
Table 6. Key Players of Immunotherapy Platform
Table 7. Key Players of Stem Cell Therapy Platform
Table 8. Key Players of Genetically Modified Cell Therapy Platform
Table 9. Global Cell therapy platform Market Size Growth Rate by Technical System (US$ Million): 2021 vs 2025 vs 2032
Table 10. Key Players of Manually Operated Platform
Table 11. Key Players of Semi-Automated Cell Therapy Platform
Table 12. Key Players of Fully Automated Closed-Loop Cell Therapy Platform
Table 13. Global Cell therapy platform Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 14. Global Cell therapy platform Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 15. Global Cell therapy platform Market Size by Region (US$ Million), 2021–2026
Table 16. Global Cell therapy platform Market Share by Region (2021–2026)
Table 17. Global Cell therapy platform Forecasted Market Size by Region (US$ Million), 2027–2032
Table 18. Global Cell therapy platform Market Share by Region (2027–2032)
Table 19. Cell therapy platform Market Trends
Table 20. Cell therapy platform Market Drivers
Table 21. Cell therapy platform Market Challenges
Table 22. Cell therapy platform Market Restraints
Table 23. Global Cell therapy platform Revenue by Players (US$ Million), 2021–2026
Table 24. Global Cell therapy platform Market Share by Players (2021–2026)
Table 25. Global Top Cell therapy platform Players by Tier (Tier 1, Tier 2, and Tier 3), based on Cell therapy platform Revenue, 2025
Table 26. Ranking of Global Top Cell therapy platform Companies by Revenue (US$ Million) in 2025
Table 27. Global 5 Largest Players Market Share by Cell therapy platform Revenue (CR5 and HHI), 2021–2026
Table 28. Global Key Players of Cell therapy platform, Headquarters and Area Served
Table 29. Global Key Players of Cell therapy platform, Products and Applications
Table 30. Global Key Players of Cell therapy platform, Date of General Availability (GA)
Table 31. Mergers and Acquisitions, Expansion Plans
Table 32. Global Cell therapy platform Market Size by Type (US$ Million), 2021–2026
Table 33. Global Cell therapy platform Revenue Market Share by Type (2021–2026)
Table 34. Global Cell therapy platform Forecasted Market Size by Type (US$ Million), 2027–2032
Table 35. Global Cell therapy platform Revenue Market Share by Type (2027–2032)
Table 36. Global Cell therapy platform Market Size by Application (US$ Million), 2021–2026
Table 37. Global Cell therapy platform Revenue Market Share by Application (2021–2026)
Table 38. Global Cell therapy platform Forecasted Market Size by Application (US$ Million), 2027–2032
Table 39. Global Cell therapy platform Revenue Market Share by Application (2027–2032)
Table 40. North America Cell therapy platform Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. North America Cell therapy platform Market Size by Country (US$ Million), 2021–2026
Table 42. North America Cell therapy platform Market Size by Country (US$ Million), 2027–2032
Table 43. Europe Cell therapy platform Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Europe Cell therapy platform Market Size by Country (US$ Million), 2021–2026
Table 45. Europe Cell therapy platform Market Size by Country (US$ Million), 2027–2032
Table 46. Asia-Pacific Cell therapy platform Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 47. Asia-Pacific Cell therapy platform Market Size by Region (US$ Million), 2021–2026
Table 48. Asia-Pacific Cell therapy platform Market Size by Region (US$ Million), 2027–2032
Table 49. Latin America Cell therapy platform Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 50. Latin America Cell therapy platform Market Size by Country (US$ Million), 2021–2026
Table 51. Latin America Cell therapy platform Market Size by Country (US$ Million), 2027–2032
Table 52. Middle East & Africa Cell therapy platform Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 53. Middle East & Africa Cell therapy platform Market Size by Country (US$ Million), 2021–2026
Table 54. Middle East & Africa Cell therapy platform Market Size by Country (US$ Million), 2027–2032
Table 55. Novartis Company Details
Table 56. Novartis Business Overview
Table 57. Novartis Cell therapy platform Product
Table 58. Novartis Revenue in Cell therapy platform Business (US$ Million), 2021–2026
Table 59. Novartis Recent Development
Table 60. Gilead Sciences Company Details
Table 61. Gilead Sciences Business Overview
Table 62. Gilead Sciences Cell therapy platform Product
Table 63. Gilead Sciences Revenue in Cell therapy platform Business (US$ Million), 2021–2026
Table 64. Gilead Sciences Recent Development
Table 65. Regeneron Pharmaceuticals Company Details
Table 66. Regeneron Pharmaceuticals Business Overview
Table 67. Regeneron Pharmaceuticals Cell therapy platform Product
Table 68. Regeneron Pharmaceuticals Revenue in Cell therapy platform Business (US$ Million), 2021–2026
Table 69. Regeneron Pharmaceuticals Recent Development
Table 70. Takeda Pharmaceuticals Company Details
Table 71. Takeda Pharmaceuticals Business Overview
Table 72. Takeda Pharmaceuticals Cell therapy platform Product
Table 73. Takeda Pharmaceuticals Revenue in Cell therapy platform Business (US$ Million), 2021–2026
Table 74. Takeda Pharmaceuticals Recent Development
Table 75. Roche Company Details
Table 76. Roche Business Overview
Table 77. Roche Cell therapy platform Product
Table 78. Roche Revenue in Cell therapy platform Business (US$ Million), 2021–2026
Table 79. Roche Recent Development
Table 80. Bluebird Bio Company Details
Table 81. Bluebird Bio Business Overview
Table 82. Bluebird Bio Cell therapy platform Product
Table 83. Bluebird Bio Revenue in Cell therapy platform Business (US$ Million), 2021–2026
Table 84. Bluebird Bio Recent Development
Table 85. Cellectis Company Details
Table 86. Cellectis Business Overview
Table 87. Cellectis Cell therapy platform Product
Table 88. Cellectis Revenue in Cell therapy platform Business (US$ Million), 2021–2026
Table 89. Cellectis Recent Development
Table 90. Sangamo Therapeutics Company Details
Table 91. Sangamo Therapeutics Business Overview
Table 92. Sangamo Therapeutics Cell therapy platform Product
Table 93. Sangamo Therapeutics Revenue in Cell therapy platform Business (US$ Million), 2021–2026
Table 94. Sangamo Therapeutics Recent Development
Table 95. Fate Therapeutics Company Details
Table 96. Fate Therapeutics Business Overview
Table 97. Fate Therapeutics Cell therapy platform Product
Table 98. Fate Therapeutics Revenue in Cell therapy platform Business (US$ Million), 2021–2026
Table 99. Fate Therapeutics Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
Table 103. Authors List of This Report
List of Figures
Figure 1. Cell therapy platform Picture
Figure 2. Global Cell therapy platform Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Cell therapy platform Market Share by Type: 2025 vs 2032
Figure 4. Autologous Cell Therapy Platform Features
Figure 5. Allogeneic Cell Therapy Platform Features
Figure 6. Others Features
Figure 7. Global Cell therapy platform Market Size Comparison by Treatment Cell Type (US$ Million), 2021–2032
Figure 8. Immunotherapy Platform Features
Figure 9. Stem Cell Therapy Platform Features
Figure 10. Genetically Modified Cell Therapy Platform Features
Figure 11. Global Cell therapy platform Market Size Comparison by Technical System (US$ Million), 2021–2032
Figure 12. Manually Operated Platform Features
Figure 13. Semi-Automated Cell Therapy Platform Features
Figure 14. Fully Automated Closed-Loop Cell Therapy Platform Features
Figure 15. Global Cell therapy platform Market Size by Application (US$ Million), 2021–2032
Figure 16. Global Cell therapy platform Market Share by Application: 2025 vs 2032
Figure 17. General Hospital Case Studies
Figure 18. Specialized Hospital Case Studies
Figure 19. Others Case Studies
Figure 20. Cell therapy platform Report Years Considered
Figure 21. Global Cell therapy platform Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 22. Global Cell therapy platform Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 23. Global Cell therapy platform Market Share by Region: 2025 vs 2032
Figure 24. Global Cell therapy platform Market Share by Players in 2025
Figure 25. Global Cell therapy platform Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 26. The Top 10 and 5 Players Market Share by Cell therapy platform Revenue in 2025
Figure 27. North America Cell therapy platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. North America Cell therapy platform Market Share by Country (2021–2032)
Figure 29. United States Cell therapy platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Canada Cell therapy platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Europe Cell therapy platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Europe Cell therapy platform Market Share by Country (2021–2032)
Figure 33. Germany Cell therapy platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. France Cell therapy platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. U.K. Cell therapy platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Italy Cell therapy platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Russia Cell therapy platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Ireland Cell therapy platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Asia-Pacific Cell therapy platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Asia-Pacific Cell therapy platform Market Share by Region (2021–2032)
Figure 41. China Cell therapy platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Japan Cell therapy platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. South Korea Cell therapy platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Southeast Asia Cell therapy platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. India Cell therapy platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Australia & New Zealand Cell therapy platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Latin America Cell therapy platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Latin America Cell therapy platform Market Share by Country (2021–2032)
Figure 49. Mexico Cell therapy platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 50. Brazil Cell therapy platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 51. Middle East & Africa Cell therapy platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 52. Middle East & Africa Cell therapy platform Market Share by Country (2021–2032)
Figure 53. Israel Cell therapy platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 54. Saudi Arabia Cell therapy platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 55. UAE Cell therapy platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 56. Novartis Revenue Growth Rate in Cell therapy platform Business (2021–2026)
Figure 57. Gilead Sciences Revenue Growth Rate in Cell therapy platform Business (2021–2026)
Figure 58. Regeneron Pharmaceuticals Revenue Growth Rate in Cell therapy platform Business (2021–2026)
Figure 59. Takeda Pharmaceuticals Revenue Growth Rate in Cell therapy platform Business (2021–2026)
Figure 60. Roche Revenue Growth Rate in Cell therapy platform Business (2021–2026)
Figure 61. Bluebird Bio Revenue Growth Rate in Cell therapy platform Business (2021–2026)
Figure 62. Cellectis Revenue Growth Rate in Cell therapy platform Business (2021–2026)
Figure 63. Sangamo Therapeutics Revenue Growth Rate in Cell therapy platform Business (2021–2026)
Figure 64. Fate Therapeutics Revenue Growth Rate in Cell therapy platform Business (2021–2026)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Table 1. Global Cell therapy platform Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Autologous Cell Therapy Platform
Table 3. Key Players of Allogeneic Cell Therapy Platform
Table 4. Key Players of Others
Table 5. Global Cell therapy platform Market Size Growth Rate by Treatment Cell Type (US$ Million): 2021 vs 2025 vs 2032
Table 6. Key Players of Immunotherapy Platform
Table 7. Key Players of Stem Cell Therapy Platform
Table 8. Key Players of Genetically Modified Cell Therapy Platform
Table 9. Global Cell therapy platform Market Size Growth Rate by Technical System (US$ Million): 2021 vs 2025 vs 2032
Table 10. Key Players of Manually Operated Platform
Table 11. Key Players of Semi-Automated Cell Therapy Platform
Table 12. Key Players of Fully Automated Closed-Loop Cell Therapy Platform
Table 13. Global Cell therapy platform Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 14. Global Cell therapy platform Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 15. Global Cell therapy platform Market Size by Region (US$ Million), 2021–2026
Table 16. Global Cell therapy platform Market Share by Region (2021–2026)
Table 17. Global Cell therapy platform Forecasted Market Size by Region (US$ Million), 2027–2032
Table 18. Global Cell therapy platform Market Share by Region (2027–2032)
Table 19. Cell therapy platform Market Trends
Table 20. Cell therapy platform Market Drivers
Table 21. Cell therapy platform Market Challenges
Table 22. Cell therapy platform Market Restraints
Table 23. Global Cell therapy platform Revenue by Players (US$ Million), 2021–2026
Table 24. Global Cell therapy platform Market Share by Players (2021–2026)
Table 25. Global Top Cell therapy platform Players by Tier (Tier 1, Tier 2, and Tier 3), based on Cell therapy platform Revenue, 2025
Table 26. Ranking of Global Top Cell therapy platform Companies by Revenue (US$ Million) in 2025
Table 27. Global 5 Largest Players Market Share by Cell therapy platform Revenue (CR5 and HHI), 2021–2026
Table 28. Global Key Players of Cell therapy platform, Headquarters and Area Served
Table 29. Global Key Players of Cell therapy platform, Products and Applications
Table 30. Global Key Players of Cell therapy platform, Date of General Availability (GA)
Table 31. Mergers and Acquisitions, Expansion Plans
Table 32. Global Cell therapy platform Market Size by Type (US$ Million), 2021–2026
Table 33. Global Cell therapy platform Revenue Market Share by Type (2021–2026)
Table 34. Global Cell therapy platform Forecasted Market Size by Type (US$ Million), 2027–2032
Table 35. Global Cell therapy platform Revenue Market Share by Type (2027–2032)
Table 36. Global Cell therapy platform Market Size by Application (US$ Million), 2021–2026
Table 37. Global Cell therapy platform Revenue Market Share by Application (2021–2026)
Table 38. Global Cell therapy platform Forecasted Market Size by Application (US$ Million), 2027–2032
Table 39. Global Cell therapy platform Revenue Market Share by Application (2027–2032)
Table 40. North America Cell therapy platform Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. North America Cell therapy platform Market Size by Country (US$ Million), 2021–2026
Table 42. North America Cell therapy platform Market Size by Country (US$ Million), 2027–2032
Table 43. Europe Cell therapy platform Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Europe Cell therapy platform Market Size by Country (US$ Million), 2021–2026
Table 45. Europe Cell therapy platform Market Size by Country (US$ Million), 2027–2032
Table 46. Asia-Pacific Cell therapy platform Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 47. Asia-Pacific Cell therapy platform Market Size by Region (US$ Million), 2021–2026
Table 48. Asia-Pacific Cell therapy platform Market Size by Region (US$ Million), 2027–2032
Table 49. Latin America Cell therapy platform Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 50. Latin America Cell therapy platform Market Size by Country (US$ Million), 2021–2026
Table 51. Latin America Cell therapy platform Market Size by Country (US$ Million), 2027–2032
Table 52. Middle East & Africa Cell therapy platform Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 53. Middle East & Africa Cell therapy platform Market Size by Country (US$ Million), 2021–2026
Table 54. Middle East & Africa Cell therapy platform Market Size by Country (US$ Million), 2027–2032
Table 55. Novartis Company Details
Table 56. Novartis Business Overview
Table 57. Novartis Cell therapy platform Product
Table 58. Novartis Revenue in Cell therapy platform Business (US$ Million), 2021–2026
Table 59. Novartis Recent Development
Table 60. Gilead Sciences Company Details
Table 61. Gilead Sciences Business Overview
Table 62. Gilead Sciences Cell therapy platform Product
Table 63. Gilead Sciences Revenue in Cell therapy platform Business (US$ Million), 2021–2026
Table 64. Gilead Sciences Recent Development
Table 65. Regeneron Pharmaceuticals Company Details
Table 66. Regeneron Pharmaceuticals Business Overview
Table 67. Regeneron Pharmaceuticals Cell therapy platform Product
Table 68. Regeneron Pharmaceuticals Revenue in Cell therapy platform Business (US$ Million), 2021–2026
Table 69. Regeneron Pharmaceuticals Recent Development
Table 70. Takeda Pharmaceuticals Company Details
Table 71. Takeda Pharmaceuticals Business Overview
Table 72. Takeda Pharmaceuticals Cell therapy platform Product
Table 73. Takeda Pharmaceuticals Revenue in Cell therapy platform Business (US$ Million), 2021–2026
Table 74. Takeda Pharmaceuticals Recent Development
Table 75. Roche Company Details
Table 76. Roche Business Overview
Table 77. Roche Cell therapy platform Product
Table 78. Roche Revenue in Cell therapy platform Business (US$ Million), 2021–2026
Table 79. Roche Recent Development
Table 80. Bluebird Bio Company Details
Table 81. Bluebird Bio Business Overview
Table 82. Bluebird Bio Cell therapy platform Product
Table 83. Bluebird Bio Revenue in Cell therapy platform Business (US$ Million), 2021–2026
Table 84. Bluebird Bio Recent Development
Table 85. Cellectis Company Details
Table 86. Cellectis Business Overview
Table 87. Cellectis Cell therapy platform Product
Table 88. Cellectis Revenue in Cell therapy platform Business (US$ Million), 2021–2026
Table 89. Cellectis Recent Development
Table 90. Sangamo Therapeutics Company Details
Table 91. Sangamo Therapeutics Business Overview
Table 92. Sangamo Therapeutics Cell therapy platform Product
Table 93. Sangamo Therapeutics Revenue in Cell therapy platform Business (US$ Million), 2021–2026
Table 94. Sangamo Therapeutics Recent Development
Table 95. Fate Therapeutics Company Details
Table 96. Fate Therapeutics Business Overview
Table 97. Fate Therapeutics Cell therapy platform Product
Table 98. Fate Therapeutics Revenue in Cell therapy platform Business (US$ Million), 2021–2026
Table 99. Fate Therapeutics Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
Table 103. Authors List of This Report
List of Figures
Figure 1. Cell therapy platform Picture
Figure 2. Global Cell therapy platform Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Cell therapy platform Market Share by Type: 2025 vs 2032
Figure 4. Autologous Cell Therapy Platform Features
Figure 5. Allogeneic Cell Therapy Platform Features
Figure 6. Others Features
Figure 7. Global Cell therapy platform Market Size Comparison by Treatment Cell Type (US$ Million), 2021–2032
Figure 8. Immunotherapy Platform Features
Figure 9. Stem Cell Therapy Platform Features
Figure 10. Genetically Modified Cell Therapy Platform Features
Figure 11. Global Cell therapy platform Market Size Comparison by Technical System (US$ Million), 2021–2032
Figure 12. Manually Operated Platform Features
Figure 13. Semi-Automated Cell Therapy Platform Features
Figure 14. Fully Automated Closed-Loop Cell Therapy Platform Features
Figure 15. Global Cell therapy platform Market Size by Application (US$ Million), 2021–2032
Figure 16. Global Cell therapy platform Market Share by Application: 2025 vs 2032
Figure 17. General Hospital Case Studies
Figure 18. Specialized Hospital Case Studies
Figure 19. Others Case Studies
Figure 20. Cell therapy platform Report Years Considered
Figure 21. Global Cell therapy platform Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 22. Global Cell therapy platform Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 23. Global Cell therapy platform Market Share by Region: 2025 vs 2032
Figure 24. Global Cell therapy platform Market Share by Players in 2025
Figure 25. Global Cell therapy platform Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 26. The Top 10 and 5 Players Market Share by Cell therapy platform Revenue in 2025
Figure 27. North America Cell therapy platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. North America Cell therapy platform Market Share by Country (2021–2032)
Figure 29. United States Cell therapy platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Canada Cell therapy platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Europe Cell therapy platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Europe Cell therapy platform Market Share by Country (2021–2032)
Figure 33. Germany Cell therapy platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. France Cell therapy platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. U.K. Cell therapy platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Italy Cell therapy platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Russia Cell therapy platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Ireland Cell therapy platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Asia-Pacific Cell therapy platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Asia-Pacific Cell therapy platform Market Share by Region (2021–2032)
Figure 41. China Cell therapy platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Japan Cell therapy platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. South Korea Cell therapy platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Southeast Asia Cell therapy platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. India Cell therapy platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Australia & New Zealand Cell therapy platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Latin America Cell therapy platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Latin America Cell therapy platform Market Share by Country (2021–2032)
Figure 49. Mexico Cell therapy platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 50. Brazil Cell therapy platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 51. Middle East & Africa Cell therapy platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 52. Middle East & Africa Cell therapy platform Market Share by Country (2021–2032)
Figure 53. Israel Cell therapy platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 54. Saudi Arabia Cell therapy platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 55. UAE Cell therapy platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 56. Novartis Revenue Growth Rate in Cell therapy platform Business (2021–2026)
Figure 57. Gilead Sciences Revenue Growth Rate in Cell therapy platform Business (2021–2026)
Figure 58. Regeneron Pharmaceuticals Revenue Growth Rate in Cell therapy platform Business (2021–2026)
Figure 59. Takeda Pharmaceuticals Revenue Growth Rate in Cell therapy platform Business (2021–2026)
Figure 60. Roche Revenue Growth Rate in Cell therapy platform Business (2021–2026)
Figure 61. Bluebird Bio Revenue Growth Rate in Cell therapy platform Business (2021–2026)
Figure 62. Cellectis Revenue Growth Rate in Cell therapy platform Business (2021–2026)
Figure 63. Sangamo Therapeutics Revenue Growth Rate in Cell therapy platform Business (2021–2026)
Figure 64. Fate Therapeutics Revenue Growth Rate in Cell therapy platform Business (2021–2026)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Trichosanthes Kirilowii Extract Market Research Report 2026
Feb 24, 26
Global Glass Lined Containers Market Research Report 2026
Feb 24, 26
Global Open End Wrenches Market Research Report 2026
Feb 24, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232